Orchard Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for OTL-103 for the Treatment of Wiskott-Aldrich Syndrome

July 29, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search